Nephrology Perspective

• HBP: What Happened in the 1930s Should Stay There   Christopher Labos, MD CM, MSc, makes sense of nearly 100 years of blood pressure recommendations.
  Medscape Family Medicine, January 03, 2025
• Consequences of Discontinuing Long-Term Drugs in HFrEF Currently patients with HF are prescribed many drugs for their lifetime. This paper reviews strategies to assess whether efficacy persists and the potential consequences of discontinuation.
  Journal of the American College of Cardiology, January 03, 2025
• Medscape 2050: The Future of Medicine As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists to envision the future of medicine in the year 2050.
  Medscape, January 01, 2025
• Preventing DKA in Patients With T1D on SGLT2 Inhibitors   Dr Anne Peters discusses how to safely prescribe SGLT2 inhibitors in patients with type 1 diabetes to prevent diabetic ketoacidosis.
  Medscape Diabetes & Endocrinology, December 23, 2024
• Heart Failure Drug Development Over the Eras A summary of current efforts of the Heart Failure Collaboratory that highlights important concepts in the contemporary landscape of HF drug development.
  JACC: Heart Failure, December 20, 2024
• “I Had No Words”: The Patient Gifts Doctors Never Forget   These doctors were surprised and moved by very personal gifts given to them by grateful patients. Enjoy some good vibes this holiday season.
  Medscape, December 19, 2024
• Episode 8: Triglycerides, HDL, and Cardiorenal Metabolic Syndrome   Join Drs Nihar Desai and Pam Taub as they discuss the nuances involved in understanding and managing triglycerides and HDL for cardiorenal metabolic syndrome.
  Medscape, December 19, 2024
• UTI in Primary Care: New Guidelines   The latest evidence-based recommendations for diagnosis, treatment, and prevention of recurrent UTI are reviewed here.
  Medscape Family Medicine, December 16, 2024
• Dec 13 2024 This Week in Cardiology   US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, December 13, 2024
• How to Avoid Freaking Out About Kidney Function   According to kidney expert Dr Joel Topf, albuminuria is a better prognostic indicator of kidney function than eGFR.
  The Curbsiders, December 13, 2024
• Takeaways From Six Substudies of the Semaglutide Trials A summary of findings from the 6 Substudies of the SELECT, STEP-HFpEF, and FLOW Trials
  Journal of the American College of Cardiology, December 06, 2024
• Gout: Diagnosis and Management in Primary Care   Physicians must consider questions related to medications, lifestyle advice, and long-term follow-up for their patients with gout.
  Medscape Family Medicine, December 12, 2024
• Good and Bad: Medscape Nurse Career Satisfaction Report 2024 Most nurses say they are happy with their career choice and would make it again. They also list their biggest job rewards and headaches, and recount experiences with abuse.
  Medscape Features Slideshows, December 12, 2024
• Mandrola’s Top 10 Stories in 2024 Cardiologist John Mandrola reviews his top 10 stories in 2024 covering beta-blockers, GLP-1s, finerenone, Impella, pulsed field ablation, tricuspid intervention, and a potential renaming of STEMI.
  theheart.org on Medscape, December 11, 2024
• Medscape Female Physician Career Tracks Report 2024 From mentorship to leadership, female physicians navigate unique challenges as they build thriving medical careers.
  Medscape Features Slideshows, December 11, 2024
• UK Doctors Sexual Harassment Report 2024 Doctors reported numerous types of harassment or assault, such as undesired texts/emails from coworkers, comments about their body, unwanted physical contact, sexual propositions, and rape.
  Medscape Features Slideshows, December 11, 2024
• ACR 2024: Clinical Impact of Lupus Nephritis Guidelines   Dr Anca Askanase examines new recommendations for triple therapy, early steroid tapering, and kidney function preservation.
  Medscape, December 10, 2024
• Medscape Female Physician Wealth & Debt Report 2024 From wealth-building to the challenges of managing debt, women physicians often play catchup on their net worth compared with male colleagues.
  Medscape Features Slideshows, December 05, 2024
• AHA 2024 Has Tirzepatide Scaled the HFpEF/Obesity SUMMIT? The GIP/GLP-1 receptor agonist reduced events in patients with HFpEF and obesity. John Mandrola questions whether it changed the disease trajectory, as the investigators claim.
  theheart.org on Medscape, December 03, 2024
• AHA 2024 REALIZE-K: A New Potassium Binder to Help Keep Spiro on Board   Heart failure expert Ileana Piña discusses potassium-binder use in patients with hyperkalemia while taking spironolactone, including results for zirconium cyclosilicate from the REALIZE-K trial.
  theheart.org on Medscape, December 03, 2024